Stemcell101.com
  • Home
  • About Us
    • About Us
    • Causes We Support
  • Stem Cell Info
    • Stem Cell Research
    • Stem Cell Applications
    • Health and Beauty
    • Pets / Animals
    • Nutrition
    • Stem Cell Blogs
    • A Stem Cell Story
  • Health Care Directory
  • Contact Us
Select Page

A study of ayahuasca users found a mental health pattern researchers cannot yet explain

by rss feed | Sep 14, 2026 | News Feeds

In a cross-sectional study of 808 Brazilian adults planning to attend ayahuasca ceremonies, greater prior experience with the brew was associated with lower depression, anxiety, and stress scores, as well as higher spiritual well-being and stronger metaphysical...

Cockroaches have a reputation for surviving almost anything, but this diet proved deadly

by rss feed | Sep 14, 2026 | News Feeds

A laboratory study tested how ultra-processed, unprocessed, and mixed diets affected survival in 127 lobster cockroaches, Nauphoeta cinerea. Cockroaches fed only ultra-processed foods had higher mortality than those given unprocessed or mixed diets, although the study...

A large US study found no overall link between fluoride in pregnancy and children’s behavior

by rss feed | Sep 14, 2026 | News Feeds

A US cohort study of 5,520 children found no overall association between prenatal exposure to fluoride in public drinking water and internalizing or externalizing behavioral problems across the primary analyses. Exploratory analyses identified some associations with...

Weekly reads: suite of reprogramming news, cancer trial reform, zombie retracted papers

by rss feed | Sep 13, 2026 | IPS cells, News Feeds, Reprogramming, weekly reads

Do you buy the idea of using in vivo reprogramming to fight aging? How about to treat certain diseases? The stream of research pubs and news articles continues to grow. Before we jump into weekly reads including on reprogramming applications, on the 20th anniversary...

Subcutaneous tarlatamab exhibits low toxicity rates in phase 1b trial

by rss feed | Sep 12, 2026 | News Feeds

Subcutaneous administration of tarlatamab was well tolerated and demonstrated preliminary antitumor activity in patients with previously treated extensive-stage small cell lung cancer (ES-SCLC), according to findings from the phase 1b DeLLphi-308 study presented at...

Phase 2 study highlights flexible dosing options for tarlatamab in relapsed SCLC

by rss feed | Sep 12, 2026 | News Feeds

Extended-interval dosing regimens of tarlatamab demonstrated efficacy, safety and pharmacokinetic profiles generally consistent with the established every-two-week regimen in patients with previously treated for small cell lung cancer (SCLC), according to results from...
« Older Entries
Next Entries »

Quick Navigation

  • Home
  • Stem Cell Info
    • Stem Cell Research
    • Stem Cell Applications
    • Health and Beauty
    • Pets / Animals
    • Nutrition
    • Stem Cell Blogs
    • A Stem Cell Story
  • Health Care Directory
  • Contact Us
  • About Us
    • About Us
    • Causes We Support

RSS Recent Post

Sign up for StemCell101.com Mailing List

By subscribing to our mailing list, you will get the latest news from us.